Press Releases Latest Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders Press Releases Year None202420232022202120202019201820172016201520142013 Nov 10, 2016 Theratechnologies Announces Results from the Last Pivotal Phase III Trial of HIV Long Acting Biologic (LAB) Investigational Antiretroviral Ibalizumab Nov 01, 2016 Theratechnologies Announces Update from its Healthcare Analyst Day Meeting Oct 28, 2016 Results of HIV Biologic and Long-Acting Investigational Antiretroviral Ibalizumab to be Presented in Late-Breaker Session at IDWeek 2016 Oct 24, 2016 Theratechnologies Announces End of Patient Treatment for Phase III Ibalizumab Trial Oct 04, 2016 Theratechnologies Announces Financial Results for Third Quarter of 2016 Sep 28, 2016 Theratechnologies to Move Forward with Development of new Single Vial Formulation for EGRIFTA® (Tesamorelin for Injection) Sep 01, 2016 Theratechnologies Announces Commercialization Agreement for Tesamorelin in Spain and Portugal Aug 18, 2016 Ibalizumab Phase III Study Primary End-Point Results To Be Presented At IDWEEK 2016 Jul 05, 2016 Theratechnologies Announces Financial Results for Second Quarter of 2016 Jun 28, 2016 Theratechnologies to announce financial results for the second quarter of 2016 First page « Previous page ‹ … Page 25 Page 26 Page 27 Page 28 Current page 29 Page 30 Page 31 Page 32 Page 33 … Next page › Last page » Displaying 281 - 290 of 360
Apr 15, 2024 Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders
Nov 10, 2016 Theratechnologies Announces Results from the Last Pivotal Phase III Trial of HIV Long Acting Biologic (LAB) Investigational Antiretroviral Ibalizumab
Oct 28, 2016 Results of HIV Biologic and Long-Acting Investigational Antiretroviral Ibalizumab to be Presented in Late-Breaker Session at IDWeek 2016
Sep 28, 2016 Theratechnologies to Move Forward with Development of new Single Vial Formulation for EGRIFTA® (Tesamorelin for Injection)
Sep 01, 2016 Theratechnologies Announces Commercialization Agreement for Tesamorelin in Spain and Portugal